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Tyrosinase is a rate-limiting enzyme of melanin biosynthesis 
and the brown (b)-locus protein is responsible for the forma­
tion of black melanin rather than brown. To identify the 
cis-acting element(s) required for pigment cell- specific gene 
transcription, we analyzed the promoter function of two pig­
ment cell-specific genes encoding mouse tyrosinase and b­
locus protein using a cell-free transcription system prepared 
P igment cells are highly differentiated cells derived from the neural crest or from the optic cup of the brain. Mela­nin, a pigment cell-specific product, plays an essential role in the protection against damage by ultraviolet light. The rate-limiting steps of melanin biosynthesis 
are catalyzed by tyrosinase (EC 1.14.18.1), a multifunctional cop­
per-containing enzyme, specifically localized in pigment cells (mel­
anocytes). Recently, another pigment cell-specific protein, en­
coded by pMT4 [1], was shown to be required for the production of 
black melanin rather than brown [2,3], although its exact function 
still remains to be elucidated. The pMT4 was cloned as a pigment 
cell-specific mouse eDNA and initially reported as a tyrosinase 
cDNA [1]. Subsequently, pMT4 was shown to map to the brown (b) 
locus on mouse chromosome 4 [4] that determines the type of mela­
nin synthesized. Both the pMT4 protein and tyrosinase share a 
significant homology (nearly 40%) [5], and are probably derived 
from a common ancestral gene. The putative functional domains or 
residues, conserved at equivalent positions of both proteins, include 
a signal peptide, 15 Cys residues, two copper-binding regions, and a 
transmembrane domain [1,5,6]. The pMT4 protein thus has been 
named tyrosinase-related protein [4]. However, the sequence re­
lated to the tyrosinase gene, the putative tyrosinase pseudo gene, 
exists in the human genome [7-9]. Thus, we tentatively use the 
term b-locus protein to designate the protein encoded by pMT4 
instead of tyrosinase-related protein [10]. 
Here I review recent progress concerning pigment cell-specific 
expression of the tyrosinase and b-locus protein genes, and discuss 
possible mechanisms for their pigment cell-specific expression. 
Reprint requests to: S. Shibahara, Department of Applied Physiology and 
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Abbreviations: 
b locus: brown locus 
bp: base pairs 
kb: kilobase pairs 
MRNA: messenger ribonucleic acid 
PCTF: pigment cell-specific transcription factor 
RNA: ribonucleic acid 
TFIID: transcription factor lID 
from mouse melanoma cells. Functional and structural analy­
sis of both gene promoters reveals that three elements are 
conserved in both genes at equivalent positions, suggesting 
that these elements may be responsible for pigment cell­
specific transcription. We discuss possible mechanisms for 
pigment cell- specific expression of the tyrosinase and b­
locus protein genes. ] Invest Dermatol1 00: 1468 -1498, 1993 
STRUCTURES OF THE MOUSE TYROSINASE AND 
b-LOCUS PROTEIN GENES 
Both tyrosinase [5,11,12] and b-Iocus protein cDNAs [1] were 
cloned by several laboratories, which allowed us to isolate and char­
acterize the genes. Such an approach is the first step to study the 
molecular mechanism for pigment cell-specific expression of the 
tyrosinase and b-locus protein genes. The mouse tyrosinase gene is 
about 100 kb and organized into five exons [13 -15] and the mouse 
b-locus protein gene is about 18 kb long and organized into eight 
exons [10,16]. Despite the fact that both genes are derived from a 
common ancestral gene, their structural organization is different. 
The human tyrosinase gene is greater than 70 kb [17,18] and lo­
cated on chromosome 11 (q14 --+ q21) [7]. Furthermore, the 
human genome contains an additional sequence on chromosome 11 
(pl1.2 --+ cen) related to the tyrosinase gene [7], which may repre­
sent a truncated tyrosinase pseudogene containing only exons 4 and 
5 [8,9,19]. Similarly, the additional sequence related to the exon 8 of 
the b-Iocus protein gene is present in the mouse genome [10]. 
ALTERNATIVELY SPLICED TRANSCRIPTS OF BOTH 
PIGMENT CELL-SPECIFIC GENES 
Alternative splicing of pre-mRNA is a commonly used mechanism 
to give rise to multiple protein isoforms encoded by a single gene. 
Indeed, the first cloned cDNA coding for mouse tyrosinase, isolated 
by Yamamoto et al [11], lacks a transmembrane region, probably 
representing an alternatively spliced transcript [13]. Alternatively 
spliced transcripts were then found in the human tyrosinase gene 
[20]. Yet, the significance of such isoforms of tyrosinase is not 
known. 
Recently, we identified the alternatively spliced transcript of the 
mouse b-Iocus protein gene by analyzing the cloned eDNA, pMT3, 
derived from mouse B16 melanoma cells [10]. The nucleotide se­
quence of pMT3 is identical to that of pMT4 except for the length 
of the 5' -untranslated region and a deletion of 103 bp (nucleotide 
residues 1678/1780), corresponding to the 5'-end of the exon 8 
se!;{uence of the pMT4-type messenger ribonucleic acid (mRNA) 
[IJ. Because the nucleotide residue 1677, preceding the deleted 
region, is the 3' -end of the exon 7, the pMT3-type mRNA is appar­
ently generated by alternative use of the 3' -splice site of intron 7, 
located within the exon 8 sequence. This deletion changes the read-
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Figure 1. Pigment cell-specific transcriptio� in lIitro of the mouse tyrosinase and b-Iocus protein genes. A. Cell-free transcription of the tyrosinase gene. Exon 
1 and its flanking regions of the BAL B/c mouse tyrosinase gene are schematically represented. ArrowheM, an additional transcription initiation site. Shown is 
the 51 probe used. the HindIII/ BgIII fragment. Asterisk, the site of end-labeling. The template DNA was the subcloned plasmid. SpAMT )11. containing the 
5' -flanking region and exon 1 of the BALB/ c mouse tyrosinase gene (26). The template DNA (40 pg/ml) was transcribed inB16 mouse melanoma whole cell 
extracts, and the products were analyzed by S1 mapping� Lane 1, the transcripts produced in the absence of a-amanitin; lane 2, the transcripts in the presence of 
a-amanitin (1 pg/ml). Two specific transcripts are indicated by a"owheads. The size markers were cp X 174 replicative form DNA fragments generated by the 
digestion with HaeIII. and given in base pairs. B. Cell-free transcription of the b-Iocus protein gene. The DNA fragments used as templates were a) the 
TaqI/Sau3Al fragment (-220/154) or b) the Fnu4HI/Sau3Al fragment (-38/154), containing the 5'-flanking region and exon 1 of the BALB/c mouse 
b-Iocus p-rotein gene. The final concentration of template DNA used for cell-free transcription was 20 pg/ml. The S1 probe used was the Ndel/ AllaI fragment 
(- 315/88). end-labeled at the AllaI site (cross), which is present only in the b-Iocus protein gene of BAL B/ c mouse. Lanes 1 and 2, the transcripts of the 
template a; lanes J and 4, the transcripts of the template b. Presence and absence of a-amanitin in the reaction mixture are indicated at the top of the gel. Arrow, 
the expected transcripts. The numbers in parentheses, shown together with restriction enzymes, indicate the 5' -terminal nucleotide generated by cleavage. 
The nucleotide residues of the b-Iocus protein gene are numbered from the transcription initiation site of the wild-type gene (10). 
ing frame and eliminates the putative transmembrane region. Thus. 
the pMT3 protein. consisting of 553 amino acids. differs only in its 
carboxyl terminus and is larger than the pMT4 protein by 16 amino 
acids. We showed that the rMT3 protein is reactive with an anti­
b-Iocus protein monoclona antibody [21.22] and suggest that this 
protein may represent a soluble isoform of the b-Iocus protein [10]. 
It is not known whether such an isoform lacking a transmembrane 
region is present in a human counterpart. However, because of a 
similarity of the human sequence to the mouse b-Iocus protein 
cDNA [23,24], it is conceivable that the human transcript coding 
for a soluble isoform can be generated by alternative splicing. 
Recent studies revealed that the melanoma antigen gp75 was 
shown to be the human homologue of the protein encoded by 
pMT4 [23]. The gp75 antigen is a melanosomal glycoprotein and is 
potentially autoimmunogenic. because IgG antibodies against gp75 
are present in the sera of a patient with metastatic melanoma [23]. 
The soluble isoform of b-Iocus protein may be related to the produc­
tion of autoantibody. Alternatively, such an isoform may possess 
catalase activity as reported by Halaban et at [25]. 
PROMOTER ACTIVITY OF THE TYROSINASE GENE 
The mouse tyrosinase gene is transcribed from two initiation sites 
[13,26]. This conclusion was based on S1 mapping and primer ex­
tension analyses of melanoma ribonucleic acid (RNA) [13] and skin 
RNA [26]. Thus, it is conceivable that the tyrosinase gene may 
possess two cis-acting elements, directing its transcription from each 
initiation site. Indeed, the sequence overlapping the TATA-like 
sequence is present about 30 bp upstream from each initiation site 
[26]. The nucleotide sequence of the promoter region of the 
BALB/c (b/b, c/c) mouse tyrosinase gene (-360/-1) [26] is identi­
cal to that of the C57BL/6 (B/B, C/C) mouse gene [14]. The 
promoter activity of the BALB/c mouse tyrosinase gene was thus 
analyzed using B16 melanoma whole cell extracts. The template 
DNA was the subcloned plasmid, SpAMT ),1, containing the 5'­
Banking region of about 2 kb and exon 1 of the tyrosinase gene [26]. 
The transcripts were identified by Sl nuclease mapping (Fig lA). 
Two major transcripts of about 120 and 180 nucleotides were sensi­
tive to a-amanitin, suggesting that the tyrosinase gene is efficiently 
transcribed from two expected initiation sites. In contrast to the 
mouse tyrosinase gene, the human gene is transcribed from one 
initiation site in vivo [27] and in vitro [18]' Indeed, the only copy of 
the TATA-like sequence is present in the human tyrosinase gene 
promoter [27]. 
The promoter function of the mouse tyrosinase gene was also 
analyzed in transgenic mice [28-30]. Recently, Kluppel et al re­
ported that only 270 bp of the 5' -Banking sequence of the mouse 
tyrosinase gene is sufficient to direct its pigment cell-specific ex­
pression [30]; the introduced gene was expressed in skin melano­
cytes and retinal pigment cells of the transgenic mice. This short 
region thus contains the cis-acting element conferring pigment cell­
specific expression. 
PROMOTER ACTIVITY OF THE MOUSE b-LOCUS 
PROTEIN GENE 
The b-Iocus protein gene was not transcribed in HeLa whole cell 
extracts [10], suggesting that HeLa cells lack some factor required 
for transcription of the pigment cell-specific gene or that the tem­
plate lacks the cis-acting element required for its transcription. We 
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Figure 2. P utative cis-acting elements found in pigment cell-specific 
genes. Nucleotide sequence of the message strand is shown. Nucleotide 
residues are numbered in the 5' to 3' direction, beginning with the major 
transcription initiation site, and the nucleotides on the 5' side of residue 1 are 
indicated by negative numbers. Shown in capital letters are the similar se­
quences present in both b-locus protein and tyrosinase genes. Nucleotide 
residues of the tyrosinase genes are numbered according to our assignment of 
its transcription initiation sites. The putative TAT A boxes are underlined. 
The mouse tyrosinase gene contains two transcription initiation sites and 
TATA boxes. 
therefore analyzed the promoter function of the b-locus protein 
gene in B16 melanoma cell-free transcription system. The DNA 
templates used were the two fragments of different lengths (Fig 1B) 
and gave rise to major transcripts of about 90 nucleotides, whi�h 
were sensitive to a-amanitin, indicating that the b-locus protem 
gene is efficiently transcribed from the expected i�itiati0!l site. I.t is 
of particular interest that �he only 3� bp of the 5 -fl�kmg regl.on seems to be sufficient to direct the pigment cell-specific transcnp­
tion in vitro. These results are consistent in part with the results of 
transient expression �ssay of the b-lo�us prot�in gene I?romot�r [16]; 
the 5'-flanking region of 370 bp IS suffiCient to direct pigment 
cell- specific expression of the reporter gene. 
PUTATIVE cis-ACTING ELEMENTS REQUIRED FOR 
PIGMENT CELL-SPECIFIC GENE EXPRESSION 
Comparison of the nucleotide sequence of the 5' -flanking region of 
the mouse b-locus protein gene with that of the mouse tyrosinase 
gene [13,14,26] reveals two similar elements, which are tentatively 
called an upstream element (-52/-38) and a pigment cell­
specific promoter (-33/-24) (Fig 2). The latter sequence of the 
b-locus protein gene is similar to a part of the TATA boxes of the 
mouse [13-15] and human tyrosinase genes [27]. Furthermore, the 
similar sequence is also present in the 5' -untranslated regions of 
tyrosinase mRNA [13,14,26,27] and b-locus protein mRNA [10], 
and thus termed a putative downstream element (Fig 2). Because the 
DNA templates used for in vitro transcription contain this sequence 
[10], it may be involved in pigment cell-specific transcription. The 
presence of such a downstream element is recently reported for glial 
fibrillary acic;lic protein gene [31], which is specifically expresse� in 
glial cells. This downstream element was proposed to be required 
for stable binding of transcription factor lID (TFIID) to the TAT A' 
box [31]. 
All information described in this review may suggest the presence 
of a transcription factor that directs pigment cell-specific gene 
expression. Tentatively this protein is termed pigment cell-specific 
transcription factor (PCTF) and a simple model is presented that 
PCTF is also specifically expressed in pigment cells (Fig 3). PCTF 
may bind to one of the elements shown in Fig 3 and activate tran­
scription of a pigment cell-specific gene. The first step for tran­
scriptional initiation is the binding of transcription factors and RNA 
polymerase II in the vicinity of the initiation site: of these tr�­
scription factors, TFIID is probably best charactenzed and crucial 
for gene transcription by RNA polymerase II (reviewed in [32]). 
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Figure 3. A possible model for pigment cell-specific gene expression. Sche­
matically represented is the structure of a pigment cell-specific gene. The 
transcription initiation site is indicated with + 1, and the direction of tran­
scription is from left to right. Note that the elements shown are not necessar­
ily related to those in Fig 2. The 5' -flanking region may contain two cis-act­
ing elements responsible for pigment cell-specific transcription. The 
downstream element may be present in exon 1 or intron 1, and is requiredfot 
stable binding of the initiation complex, consisting of TFIID, RNA polym­
erase II and other factors. PCTF may directly bind to some element and 
activate transcription by interacting with initiation complex. Alternatively, 
PCTF may cooperate with other factors to form the stable initiation com­
plex. 
PCTF may be required for the formation of a stable complex con­
sisting of TFIID and RNA polymerase II; namely, PCTF may coop­
erate with TFIID and/or other factors to form a stable initiation 
complex. Alternatively, PCTF bound to the upstream enhancer 
may activate transcription by interacting with the initiation com­
plex. Thus, cells lacking PCTF are unable to transcribe the tyrosin­
ase and b-locus protein genes. 
Recently, we found that the promoters of the human pigment 
cell-specific genes are not equivalent to those of the mouse counter­
parts l33,34]. In contrast to the mouse b-locus protein gene [10,161, 
the promoter region of the human homolog (about -970/-1) is 
not sufficient to direct its pigment cell-specific expression in cul­
tured cells [33]. We also suggested that the intron 1 of the human 
homolog enhances its expression, which, however, is not in a pig­
ment cell-specific manner [33]. Thus, it is conceivable that this 
intron 1 may contain a downstream element, as shown in Fig 3, that 
is bound by a general transcription factor. Yet, the upstream en­
hancer responsible for pigment cell-specific expression is not found 
in the 5' -flanking region of the human homolog of the mouse 
b-locus protein gene. Furthermore, in spite of a sequence similarity 
in the pigment cell-specific promoter (Fig 2), the human tyrosinase 
gene promoter of about 600 bp is not so efficient in pigment cell­
specificity as the mouse gene promoter of 270 bp [34]. We thus 
found that the pigment cell-specific enhancer is located about 2 kb 
upstream from the transcription initiation site of the human tyro­
sinase gene [34]. We assume that PCTF may bind to this enhancer 
element (Fig 3). Purification and molecular cloning of PCTF may 
lead us to understand the molecular mechanism for pigment cell­
specific gene expression. 
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